Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | EVP, Chief Strategy Officer | August 15, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date August 15, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,396 |
Ending reported balance
After 2026-08-15 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-15 · Exercise / conversion · Acquired 1,097 · Balance 1,097 Row 2 · 2026-08-15 · Tax withholding · Disposed 589 · Balance 508 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. Row 3 · 2026-08-15 · Exercise / conversion · Acquired 1,917 · Balance 2,425 Row 4 · 2026-08-15 · Tax withholding · Disposed 1,029 · Balance 1,396 F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 3,290 |
Reported balance
After 2026-08-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-15 · Exercise / conversion · Disposed 1,097 · Balance 3,290 F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 13,418 |
Reported balance
After 2026-08-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-15 · Exercise / conversion · Disposed 1,917 · Balance 13,418 F6: Awarded on May 30, 2025 pursuant to the 2023 Plan. F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 33,109 |
Reported balance
Holding disclosure · report date 2026-08-15 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 33,109 F2: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Issuer to satisfy tax withholding requirements upon the vesting of restricted stock units (RSUs). No shares were sold.
F2: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.
F3: Awarded on May 23, 2024 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F4: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F5: One-third of the RSUs granted on May 23, 2024 vested on May 15, 2025, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
F6: Awarded on May 30, 2025 pursuant to the 2023 Plan.
F7: One-third of the RSUs granted on May 30, 2025 vested on May 15, 2026, with the remaining RSUs vesting in eight (8) equal quarterly installments thereafter, subject to the terms of the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 67 | $43.11 | $2,888.37 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000243 · wf-form4_166984355040179.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,236 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 129 | $39.54 | $5,100.66 |
DisclosureSEC source: 0001438133-22-000243 · wf-form4_166984355040179.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,017 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 28, 2022 Filed Nov 30, 2022 21:26 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000243 · wf-form4_166984355040179.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 23:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000227 · wf-form4_166872854271943.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,624 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 23:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 57 | $42.27 | $2,409.39 |
DisclosureSEC source: 0001438133-22-000227 · wf-form4_166872854271943.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,774 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 23:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000227 · wf-form4_166872854271943.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:48 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000201 · wf-form4_166197888783515.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:48 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 129 | $46.68 | $6,021.72 |
DisclosureSEC source: 0001438133-22-000201 · wf-form4_166197888783515.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,668 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 29, 2022 Filed Aug 31, 2022 20:48 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000201 · wf-form4_166197888783515.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000187 · wf-form4_166077005780446.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 57 | $55.25 | $3,149.25 |
DisclosureSEC source: 0001438133-22-000187 · wf-form4_166077005780446.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,424 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000187 · wf-form4_166077005780446.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:20 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000145 · wf-form4_165412919287225.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,981 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan ("the 2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:20 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 129 | $70.81 | $9,134.49 |
DisclosureSEC source: 0001438133-22-000145 · wf-form4_165412919287225.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 27, 2022 Filed Jun 2, 2022 00:20 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000145 · wf-form4_165412919287225.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:47 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 8,544 | $0.00 Strike: $65.28 | $0.00 |
DisclosureSEC source: 0001438133-22-000124 · wf-form4_165370242297147.xml · derivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544 Underlying: Common Stock · 8,544 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.exercise_date: The option shall vest as to thirty-three percent (33%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in twenty-four (24) equal monthly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:47 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantPerformance Stock Unit · Derivative | 5,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000124 · wf-form4_165370242297147.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,523 Underlying: Common Stock · 5,523 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F4 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. F4 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:47 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantRestricted Stock Unit · Derivative | 5,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000124 · wf-form4_165370242297147.xml · derivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,691 Underlying: Common Stock · 5,691 shares Expires not disclosed F1 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000073 · wf-form4_165291268503991.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 225 | $73.85 | $16,616.25 |
DisclosureSEC source: 0001438133-22-000073 · wf-form4_165291268503991.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,075 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000073 · wf-form4_165291268503991.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,354 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 153 | $112.43 | $17,201.79 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 287 | $82.34 Strike: $82.34 | $23,631.58 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · derivative · entry 6 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,314 Underlying: Common Stock · 287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 797 | $89.54 Strike: $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,717 Underlying: Common Stock · 797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 714 | $151.63 | $108,263.82 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $151.99. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 370 | $150.84 | $55,810.80 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,145 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 287 | $82.34 | $23,631.58 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 797 | $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 286 | $82.34 Strike: $82.34 | $23,549.24 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,601 Underlying: Common Stock · 286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 797 | $89.54 Strike: $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · derivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,514 Underlying: Common Stock · 797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,083 | $140.00 | $151,620.00 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 286 | $82.34 | $23,549.24 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,514 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:24 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 797 | $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000228 · wf-form4_163908503560052.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,726 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 185 | $129.66 | $23,987.10 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| November 29, 2021 Filed Dec 2, 2021 00:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000218 · wf-form4_163840525190692.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 4,874 | $82.34 Strike: $82.34 | $401,325.16 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 Underlying: Common Stock · 4,874 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionStock Option · Derivative | 15,936 | $89.54 Strike: $89.54 | $1,426,909.44 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · derivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,311 Underlying: Common Stock · 15,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 21,785 | $140.02 | $3,050,407.59 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $140.00 to $140.18. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 4,874 | $82.34 | $401,325.16 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:59 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 15,936 | $89.54 | $1,426,909.44 |
DisclosureSEC source: 0001438133-21-000203 · wf-form4_163614598204986.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,099 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Tax withholdingCommon Stock | 129 | $110.31 | $14,229.99 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 20:34 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-21-000149 · wf-form4_163044205077949.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.